Inflammatory potential of the diet and association with risk of differentiated thyroid cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 28 01 2022
accepted: 21 04 2022
pubmed: 1 6 2022
medline: 14 9 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

Chronic inflammation is thought to initiate or promote differentiated thyroid cancer (DTC) and previous studies have shown that diet can modulate this inflammatory process. We aimed to evaluate the association of several dietary scores reflecting the inflammatory potential of the diet with DTC risk. Within the EPIC cohort, 450,063 participants were followed during a mean period of 14 years, and 712 newly incident DTC cases were identified. Associations between four dietary inflammatory scores [the dietary inflammatory index (DII Positive associations were observed between DTC risk and the DIIs (HR for 1 SD increase in DII: 1.11, 95%CI: 1.01, 1.23, similar results for its derivatives), but not with the ISD (HR for 1 SD increase: 1.04, 95% CI 0.93, 1.16). Diet-associated inflammation, as estimated by the DII and its derivatives, was weakly positively associated with DTC risk in a European adult population. These results suggesting that diet-associated inflammation acts in the etiology of DTC need to be validated in independent studies.

Identifiants

pubmed: 35635567
doi: 10.1007/s00394-022-02897-w
pii: 10.1007/s00394-022-02897-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3625-3635

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
doi: 10.3322/caac.21492 pubmed: 30207593
Pellegriti G, Frasca F, Regalbuto C et al (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013:965212. https://doi.org/10.1155/2013/965212
doi: 10.1155/2013/965212 pubmed: 23737785 pmcid: 3664492
Ito Y, Nikiforov YE, Schlumberger M, Vigneri R (2013) Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol 9:178–184. https://doi.org/10.1038/nrendo.2012.257
doi: 10.1038/nrendo.2012.257 pubmed: 23358352
Lim H, Devesa SS, Sosa JA et al (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317:1338–1348. https://doi.org/10.1001/jama.2017.2719
doi: 10.1001/jama.2017.2719 pubmed: 28362912 pmcid: 8216772
Ron E, Lubin JH, Shore RE et al (2012) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. 1995. Radiat Res 178:AV43–AV60. https://doi.org/10.1667/rrav05.1
doi: 10.1667/rrav05.1 pubmed: 22870979
Kitahara CM, McCullough ML, Franceschi S et al (2016) Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies. Thyroid 26:306–318. https://doi.org/10.1089/thy.2015.0319
doi: 10.1089/thy.2015.0319 pubmed: 26756356 pmcid: 4754509
Caini S, Gibelli B, Palli D et al (2015) Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies. Cancer Causes Control 26:511–518. https://doi.org/10.1007/s10552-015-0546-z
doi: 10.1007/s10552-015-0546-z pubmed: 25754110
Zamora-Ros R, Rinaldi S, Tsilidis KK et al (2016) Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer 138:65–73. https://doi.org/10.1002/ijc.29693
doi: 10.1002/ijc.29693 pubmed: 26190646
Xiao Q, Park Y, Hollenbeck AR, Kitahara CM (2014) Dietary flavonoid intake and thyroid cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomark Prev 23:1102–1108. https://doi.org/10.1158/1055-9965.EPI-13-1150
doi: 10.1158/1055-9965.EPI-13-1150
Xie L, Mo M, Jia H-X et al (2016) Association between dietary nitrate and nitrite intake and sitespecific cancer risk: evidence from observational studies. Oncotarget 7:56915–56932. https://doi.org/10.18632/oncotarget.10917
doi: 10.18632/oncotarget.10917 pubmed: 27486968 pmcid: 5302962
Cao L-Z, Peng X-D, Xie J-P et al (2017) The relationship between iodine intake and the risk of thyroid cancer: a meta-analysis. Medicine (Baltimore) 96:e6734. https://doi.org/10.1097/MD.0000000000006734
doi: 10.1097/MD.0000000000006734
Bosetti C, Negri E, Kolonel L et al (2002) A pooled analysis of case-control studies of thyroid cancer. VII. Cruciferous and other vegetables (International). Cancer Causes Control 13:765–775. https://doi.org/10.1023/a:1020243527152
doi: 10.1023/a:1020243527152 pubmed: 12420956
Hong S-H, Myung S-K, Kim HS, Korean Meta-Analysis (KORMA) Study Group (2017) Alcohol intake and risk of thyroid cancer: a meta-analysis of observational studies. Cancer Res Treat 49:534–547. https://doi.org/10.4143/crt.2016.161
doi: 10.4143/crt.2016.161 pubmed: 27456949
Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444. https://doi.org/10.1038/nature07205
doi: 10.1038/nature07205 pubmed: 18650914
Phillips CM, Chen L-W, Heude B et al (2019) Dietary inflammatory index and non-communicable disease risk: a narrative review. Nutrients 11:E1873. https://doi.org/10.3390/nu11081873
doi: 10.3390/nu11081873 pubmed: 31408965
Marx W, Veronese N, Kelly JT et al (2021) The dietary inflammatory index and human health: an umbrella review of meta-analyses of observational studies. Adv Nutr 12:1681–1690. https://doi.org/10.1093/advances/nmab037
doi: 10.1093/advances/nmab037 pubmed: 33873204 pmcid: 8483957
Lai X, Xia Y, Zhang B et al (2017) A meta-analysis of Hashimoto’s thyroiditis and papillary thyroid carcinoma risk. Oncotarget 8:62414–62424. https://doi.org/10.18632/oncotarget.18620
doi: 10.18632/oncotarget.18620 pubmed: 28977955 pmcid: 5617515
Zhao ZG, Guo XG, Ba CX et al (2012) Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res 40:2041–2050. https://doi.org/10.1177/030006051204000601
doi: 10.1177/030006051204000601 pubmed: 23321160
Stanciu AE, Serdarevic N, Hurduc AE, Stanciu MM (2015) IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto’s thyroiditis. Scand J Clin Lab Invest 75:539–548. https://doi.org/10.3109/00365513.2015.1057895
doi: 10.3109/00365513.2015.1057895 pubmed: 26305420
Dossus L, Franceschi S, Biessy C et al (2018) Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study. Int J Cancer 142:1332–1342. https://doi.org/10.1002/ijc.31172
doi: 10.1002/ijc.31172 pubmed: 29168186
Minihane AM, Vinoy S, Russell WR et al (2015) Low-grade inflammation, diet composition and health: current research evidence and its translation. Br J Nutr 114:999–1012. https://doi.org/10.1017/S0007114515002093
doi: 10.1017/S0007114515002093 pubmed: 26228057 pmcid: 4579563
Galland L (2010) Diet and inflammation. Nutr Clin Pract 25:634–640. https://doi.org/10.1177/0884533610385703
doi: 10.1177/0884533610385703 pubmed: 21139128
Cavicchia PP, Steck SE, Hurley TG et al (2009) A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr 139:2365–2372. https://doi.org/10.3945/jn.109.114025
doi: 10.3945/jn.109.114025 pubmed: 19864399 pmcid: 2777480
Shivappa N, Steck SE, Hurley TG et al (2014) Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr 17:1689–1696. https://doi.org/10.1017/S1368980013002115
doi: 10.1017/S1368980013002115 pubmed: 23941862
van Woudenbergh GJ, Theofylaktopoulou D, Kuijsten A et al (2013) Adapted dietary inflammatory index and its association with a summary score for low-grade inflammation and markers of glucose metabolism: the Cohort study on Diabetes and Atherosclerosis Maastricht (CODAM) and the Hoorn study. Am J Clin Nutr 98:1533–1542. https://doi.org/10.3945/ajcn.112.056333
doi: 10.3945/ajcn.112.056333 pubmed: 24153342
Agudo A, Cayssials V, Bonet C et al (2018) Inflammatory potential of the diet and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr 107:607–616. https://doi.org/10.1093/ajcn/nqy002
doi: 10.1093/ajcn/nqy002 pubmed: 29635497
Paquet M, Shivappa N, Hébert JR et al (2020) Dietary inflammatory index and differentiated thyroid carcinoma risk: a population-based case-control study in New Caledonia. Am J Epidemiol 189:95–107. https://doi.org/10.1093/aje/kwz192
doi: 10.1093/aje/kwz192 pubmed: 31509174
Lécuyer L, Laouali N, Hajji-Louati M et al (2021) Adapted dietary inflammatory index and differentiated thyroid carcinoma risk in two French population-based case–control studies. Eur J Nutr. https://doi.org/10.1007/s00394-021-02721-x
doi: 10.1007/s00394-021-02721-x pubmed: 34718861
Riboli E, Hunt KJ, Slimani N et al (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113–1124. https://doi.org/10.1079/PHN2002394
doi: 10.1079/PHN2002394 pubmed: 12639222
Riboli E, Kaaks R (1997) The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26(Suppl 1):S6-14. https://doi.org/10.1093/ije/26.suppl_1.s6
doi: 10.1093/ije/26.suppl_1.s6 pubmed: 9126529
Margetts BM, Pietinen P (1997) European Prospective Investigation into Cancer and Nutrition: validity studies on dietary assessment methods. Int J Epidemiol 26(Suppl 1):S1-5. https://doi.org/10.1093/ije/26.suppl_1.s1
doi: 10.1093/ije/26.suppl_1.s1 pubmed: 9126528
Slimani N, Deharveng G, Unwin I et al (2007) The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 61:1037–1056. https://doi.org/10.1038/sj.ejcn.1602679
doi: 10.1038/sj.ejcn.1602679 pubmed: 17375121
Sierksma A, van der Gaag MS, Kluft C, Hendriks HFJ (2002) Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr 56:1130–1136. https://doi.org/10.1038/sj.ejcn.1601459
doi: 10.1038/sj.ejcn.1601459 pubmed: 12428180
Avellone G, Di Garbo V, Campisi D et al (2006) Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. Eur J Clin Nutr 60:41–47. https://doi.org/10.1038/sj.ejcn.1602265
doi: 10.1038/sj.ejcn.1602265 pubmed: 16132058
Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S-1228S. https://doi.org/10.1093/ajcn/65.4.1220S (discussion 1229S–1231S)
doi: 10.1093/ajcn/65.4.1220S pubmed: 9094926
Julia C, Assmann KE, Shivappa N et al (2017) Long-term associations between inflammatory dietary scores in relation to long-term C-reactive protein status measured 12 years later: findings from the Supplémentation en Vitamines et Minéraux Antioxydants (SU.VI.MAX) cohort. Br J Nutr 117:306–314. https://doi.org/10.1017/S0007114517000034
doi: 10.1017/S0007114517000034 pubmed: 28166841
Hébert JR, Shivappa N, Wirth MD et al (2019) Perspective: the Dietary Inflammatory Index (DII)-lessons learned, improvements made, and future directions. Adv Nutr 10:185–195. https://doi.org/10.1093/advances/nmy071
doi: 10.1093/advances/nmy071 pubmed: 30615051 pmcid: 6416047
Sen A, Tsilidis KK, Allen NE et al (2015) Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study. Br J Cancer 113:840–847. https://doi.org/10.1038/bjc.2015.280
doi: 10.1038/bjc.2015.280 pubmed: 26313664 pmcid: 4559837
Zahedi H, Djalalinia S, Asayesh H et al (2020) A higher dietary inflammatory index score is associated with a higher risk of incidence and mortality of cancer: a comprehensive systematic review and meta-analysis. Int J Prev Med 11:15. https://doi.org/10.4103/ijpvm.IJPVM_332_18
doi: 10.4103/ijpvm.IJPVM_332_18 pubmed: 32175055 pmcid: 7050224
Castro-Espin C, Agudo A, Bonet C et al (2021) Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study. Eur J Epidemiol. https://doi.org/10.1007/s10654-021-00772-2
doi: 10.1007/s10654-021-00772-2 pubmed: 34148186
Zamora-Ros R, Béraud V, Franceschi S et al (2018) Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Cancer 142:449–459. https://doi.org/10.1002/ijc.30880
doi: 10.1002/ijc.30880 pubmed: 28688112
Zamora-Ros R, Castañeda J, Rinaldi S et al (2017) Consumption of fish is not associated with risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. J Nutr 147:1366–1373. https://doi.org/10.3945/jn.117.247874
doi: 10.3945/jn.117.247874 pubmed: 28592517
Liu Z-T, Lin A-H (2014) Dietary factors and thyroid cancer risk: a meta-analysis of observational studies. Nutr Cancer 66:1165–1178. https://doi.org/10.1080/01635581.2014.951734
doi: 10.1080/01635581.2014.951734 pubmed: 25256273
Pagano L, Mele C, Sama MT et al (2018) Thyroid cancer phenotypes in relation to inflammation and autoimmunity. Front Biosci (Landmark Ed) 23:2267–2282
doi: 10.2741/4705
Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785–1788. https://doi.org/10.1172/JCI20514
doi: 10.1172/JCI20514 pubmed: 14679172 pmcid: 297006
Kaaks R, Slimani N, Riboli E (1997) Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26(Suppl 1):S26-36. https://doi.org/10.1093/ije/26.suppl_1.s26
doi: 10.1093/ije/26.suppl_1.s26 pubmed: 9126531

Auteurs

Lucie Lécuyer (L)

Paris-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807, Villejuif, France.

Nasser Laouali (N)

Paris-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807, Villejuif, France.
Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USA.

Laure Dossus (L)

Section of Nutrition and Metabolism, International Agency for Research On Cancer, 150, Cours Albert Thomas, 69008, Lyon, France.

Nitin Shivappa (N)

Cancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

James R Hébert (JR)

Cancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.

Anne Tjonneland (A)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Danish Cancer Society Research Center, Institute of Cancer Epidemiology, Copenhagen, Denmark.

Jytte Halkjaer (J)

Danish Cancer Society Research Center, Institute of Cancer Epidemiology, Copenhagen, Denmark.

Kim Overvad (K)

Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.

Verena A Katzke (VA)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Charlotte Le Cornet (C)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Institute of Nutritional Science, University of Potsdam, Potsdam, Germany.

Franziska Jannasch (F)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Institute of Nutritional Science, University of Potsdam, Potsdam, Germany.

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Claudia Agnoli (C)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Rosario Tumino (R)

Hyblean Association for Epidemiological Research, A.I.R.E.-O.N.L.U.S., Ragusa, Italy.

Luca Dragna (L)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, 10126, Turin, Italy.

Gabriella Iannuzzo (G)

Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.

Torill Enget Jensen (TE)

Department of Community Medicine, The Arctic University of Norway, Tromsø, Norway.

Magritt Brustad (M)

Department of Community Medicine, The Arctic University of Norway, Tromsø, Norway.
The Public Dental Service Competence Centre of Northern Norway (TkNN), Tromsø, Norway.

Guri Skeie (G)

Department of Community Medicine, The Arctic University of Norway, Tromsø, Norway.

Raul Zamora-Ros (R)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.

Miguel Rodriguez-Barranco (M)

Escuela Andaluza de Salud Pública (EASP), 18011, Granada, Spain.
Instituto de Investigación Biosanitaria Ibs.GRANADA, 18012, Granada, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.

Pilar Amiano (P)

Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, San Sebastián, Spain.
Epidemiology of Chronic and Communicable Diseases Group, Biodonostia Health Research Institute, San Sebastián, Spain.
Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.

María-Dolores Chirlaque (MD)

Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.
CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Eva Ardanaz (E)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

Martin Almquist (M)

Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden.
Department of Surgery Section of Endocrine and Sarcoma Lund, Skåne University Hospital, Lund University, Lund, Sweden.

Emily Sonestedt (E)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Maria Sandström (M)

Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.

Lena Maria Nilsson (LM)

Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.

Elisabete Weiderpass (E)

International Agency for Research On Cancer, Lyon, France.

Inge Huybrechts (I)

Section of Nutrition and Metabolism, International Agency for Research On Cancer, 150, Cours Albert Thomas, 69008, Lyon, France.

Sabina Rinaldi (S)

Section of Nutrition and Metabolism, International Agency for Research On Cancer, 150, Cours Albert Thomas, 69008, Lyon, France.

Marie-Christine Boutron-Ruault (MC)

Paris-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807, Villejuif, France.

Thérèse Truong (T)

Paris-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807, Villejuif, France. therese.truong@inserm.fr.
Team Exposome and Heredity, Inserm U1018, CESP, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France. therese.truong@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH